Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apogent Technologies was a leading developer and manufacturer of value-added laboratory products for the healthcare and life science markets. The company operated through two primary segments: Laboratory Products and Clinical Diagnostics, offering a wide range of plasticware, glassware, and liquid handling systems. Its portfolio included well-known brands such as Nalgene, Nunc, and Barnstead, which provided essential tools for research, drug discovery, and clinical testing. In 2004, Apogent was acquired by Fisher Scientific International in a deal valued at approximately $3.7 billion, significantly expanding Fisher's laboratory equipment offerings. Today, its legacy products continue to be a core part of the Thermo Fisher Scientific portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apogent Technologies.